Add BrightSurf on Google Email

Mass General Brigham


Long-term ‘Food is Medicine’ program associated with improved adult cardiometabolic health

A new study by Mass General Brigham researchers shows that a longer duration Food Is Medicine program associated with improved adult cardiometabolic health. Participants who received weekly plant-based grocery packages for 2.7 years showed dose-dependent reductions in diastolic blood pressure, body weight, and BMI.

SourceMass General Brigham·JournalPreventing Chronic Disease·TypeData/statistical analysis·DateOct 2, 2026

Research Spotlight: Exercise as medicine—how exercise protects joints in aging-related osteoarthritis

Researchers discovered that moderate-intensity exercise significantly improved cartilage health and tissue resilience in aging-related osteoarthritis. The molecular cargo of extracellular vesicles was found to be enriched with microRNA-29, which restored youthful characteristics in cartilage cells and reduced joint degeneration features.

SourceMass General Brigham·JournalNature Aging·TypeExperimental study·DateSep 29, 2026

Could earlier recognition of cerebral visual impairment in the NICU help more children thrive?

A new clinical practice guideline aims to standardize the identification and management of infants at increased risk for cerebral visual impairment (CVI). The guideline recommends comprehensive ophthalmologic evaluation and referral to developmental services within the first six months of life to access interventions as early as possible.

SourceMass General Brigham·JournalNature·TypeSurvey·DateSep 29, 2026

Heavily immunosuppressed patients undergoing anticancer immunotherapy face increased risk of severe infections

A retrospective analysis of 20,000 patient records found that patients receiving immunotherapy and multiple immunosuppressive therapies were at higher risk of severe infections. Treatment with multiple immunosuppressive therapies was associated with increased rates and severity of infection.

SourceMass General Brigham·JournalJournal of the National Comprehensive Cancer Network·TypeObservational study·DateSep 24, 2026

Novel CAR-T therapy shows promising safety and durable responses in hard-to-treat multiple myeloma

A Phase 1 clinical trial found that an investigational CAR-T therapy, anito-cel, led to high response rates and durable benefits in patients with relapsed/refractory multiple myeloma. Serious side effects were uncommon, and no delayed neurological complications were reported.

SourceMass General Brigham·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 24, 2026

Research provides clues to spleen’s role in coronary artery disease

Researchers found associations between splenic features and coronary artery disease in a large dataset, suggesting new targets for prevention and treatment. The study used artificial intelligence and imaging scans to identify CAD-relevant splenic features, shedding light on novel mechanisms linking the spleen to heart disease.

SourceMass General Brigham·JournalScience Translational Medicine·TypeImaging analysis·DateSep 9, 2026

How a pig-kidney xenotransplant served as a successful bridge to human transplant for patient with end-stage kidney disease

Researchers report successful xenotransplantation of genetically edited pig kidney to patient with end-stage kidney disease, achieving longest dialysis-free survival of 271 days. The study highlights the potential of xenotransplantation as a bridge to human transplant, addressing the organ shortage crisis.

SourceMass General Brigham·JournalThe Lancet·TypeExperimental study·DateSep 3, 2026

Mass General Brigham-led trial shows a less-intensive drug combination is more effective in treating AML

A phase 2 clinical trial found that a less-intensive combination of azacitidine and venetoclax was more effective in treating acute myeloid leukemia, with patients tolerating treatment better and spending less time in the hospital. The combination also led to more patients reaching stem cell transplantation.

SourceMass General Brigham·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 2, 2026

LDL-cholesterol lowering medication linked to lower mortality in high-risk patients without a prior heart attack or stroke

High-risk patients taking evolocumab had a 20% lower risk of death compared to those on placebo, according to a Mass General Brigham study. The study found that intensive LDL-C lowering with evolocumab was associated with lower risk of heart attack and stroke, as well as improved survival in high-risk patients without a prior CV event.

SourceMass General Brigham·JournalCirculation·TypeRandomized controlled/clinical trial·DateAug 31, 2026

At least 1-in-4 former NFL players who died between 2016-2021 had CTE, study finds

A study by Mass General Brigham, Boston University, and the Concussion & CTE Foundation found that at least 1-in-4 former NFL players who died between 2016 and 2021 had chronic traumatic encephalopathy (CTE), with 61.3% of NFL donors with CTE meeting clinical criteria for dementia. The study also found that dementia was common among br...

SourceMass General Brigham·JournalThe BMJ·TypeData/statistical analysis·DateAug 25, 2026

Study finds people who consumed sugar-sweetened beverages on a daily basis had higher risk of stomach cancer

Consuming at least one sugar-sweetened beverage per day increases gastric cancer risk by over twice, while artificially sweetened beverages show no association. The study analyzed data from over 100,000 participants and found a significant link between high fructose intake and greater gastric cancer incidence.

SourceMass General Brigham·JournalGastro Hep Advances·TypeObservational study·DateAug 17, 2026

Women who experienced adverse pregnancy outcomes had higher health-related social needs

A study by Mass General Brigham researchers found that preeclampsia, preterm birth, gestational diabetes, and other adverse outcomes were associated with greater social needs, such as inadequate food, employment, and education among Black and Latina women. Integrating social needs assessment into postpartum care could improve long-term...

SourceMass General Brigham·JournalJAMA Network Open·TypeData/statistical analysis·DateAug 12, 2026

Preclinical study suggests restoring inhibitory neuron plasticity may reverse neurodevelopmental disorder symptoms

A preclinical study suggests that restoring inhibitory neuron plasticity may reverse symptoms of neurodevelopmental disorders (NDDs) such as autism spectrum disorder and epilepsy. By boosting Meis2 expression in parvalbumin inhibitory neurons, the researchers restored experience-dependent plasticity and improved spatial and social memory.

SourceMass General Brigham·JournalNature·TypeObservational study·DateAug 12, 2026

New study suggests genomic newborn screening could identify some children at risk for early cancers

A new study suggests that genetic testing added to routine newborn screening can identify babies at increased risk of developing cancer before symptoms appear. The study found pathogenic or likely pathogenic variants in 132 children, nearly seven percent of the group, linked to pediatric cancer predisposition syndromes.

SourceMass General Brigham·JournalNature Communications·TypeObservational study·DateAug 12, 2026

Study finds most patients with early Alzheimer’s disease pursuing anti-amyloid antibody therapy are not following guidelines for promoting brain health

A study published in The Journal of Prevention of Alzheimer's Disease found that patients with early Alzheimer's disease are often not adhering to brain health recommendations, including exercise and healthy eating. Most patients pursue anti-amyloid antibody therapy but still fall short of optimal brain health guidelines.

SourceMass General Brigham·JournalThe Journal of Prevention of Alzheimer s Disease·TypeObservational study·DateAug 7, 2026

Study demonstrates the impact of expanding mobile addiction clinics

A study published in International Journal of Environmental Research and Public Health reveals that mobile addiction services can effectively treat people who use drugs, particularly those disconnected from traditional care. The Mass General Brigham Kraft Center for Community Health model proved successful in improving outcomes and red...

SourceMass General Brigham·JournalInternational Journal of Environmental Research and Public Health·TypeSystematic review·DateJul 28, 2026

Study finds 1 in 3 Americans without heart disease miss new cholesterol goals—and 3 in 4 go untreated

A study by Mass General Brigham found that nearly 1 in 3 US adults without heart disease have LDL levels above the recommended goal, and 3 in 4 are not receiving any cholesterol-lowering medication. The gap is wider among those with established heart disease, where most are already receiving therapy but still not reaching goals.

SourceMass General Brigham·JournalJAMA·TypeObservational study·DateJul 20, 2026

Clinical trial finds oral drug keeps cancer treatment on track for patients who develop persistently low platelet counts

A phase 2 trial found that avatrombopag was safe and effective in managing persistent chemotherapy-induced thrombocytopenia, a common complication from cancer treatment. The oral drug helped 70% of patients with low platelet counts stay on their chemotherapy schedule, compared to 17% receiving placebo.

SourceMass General Brigham·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateJul 20, 2026

Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early

A blood-based test for the biomarker p-tau217 has been shown to predict the risk of developing cognitive impairment due to Alzheimer's disease up to a decade earlier than previously thought. The study found that individuals with very high levels of p-tau217 had a 38% absolute risk of developing cognitive impairment over five years, and...

SourceMass General Brigham·JournalJAMA·TypeObservational study·DateJul 15, 2026

Virtual, sustained smoking cessation program for cancer patients doubles quitting rate, clinical trial shows

A new study found that a virtual smoking cessation treatment program nearly doubled quit rates for cancer patients who currently smoke. The program, delivered at community oncology care settings, was both cost-effective and satisfying for patients. Participants who completed more sessions had a higher likelihood of quitting.

SourceMass General Brigham·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateJul 14, 2026

Tuberculosis vaccine changes brain’s immune environment and Alzheimer’s biomarkers in older adults

A new study found that BCG vaccines can modify Alzheimer's biomarkers in non-Alzheimer's participants, suggesting a potential biological explanation for the observed link between BCG vaccination and lower disease risk. The vaccine also promoted increased immune responses in healthy participants without Alzheimer's pathology.

SourceMass General Brigham·JournalCommunications Medicine·TypeRandomized controlled/clinical trial·DateJul 6, 2026

Investigators identify blood protein signature for non-invasive diagnosis of pediatric inflammatory bowel disease

A team of researchers has identified a distinct blood protein pattern that can accurately diagnose pediatric inflammatory bowel disease and differentiate between its two main forms. The discovery, using proteomics technology, showed high accuracy in identifying IBD and distinguishing ulcerative colitis from Crohn's disease.

SourceMass General Brigham·JournalEBioMedicine·TypeSystematic review·DateJun 23, 2026

New benchmark evaluates AI for everyday patient care

Researchers developed BRIDGE, a multilingual benchmark that assesses large language models' understanding of clinical patient-care text. The benchmark reveals significant gaps in LLM performance on real-world clinical tasks, particularly in nuanced clinical language.

SourceMass General Brigham·JournalNature Biomedical Engineering·TypeComputational simulation/modeling·DateJun 17, 2026

Research spotlight: People with traumatic brain injury more likely to die from brain cancer than general population

A study published in Neuroepidemiology found that individuals with traumatic brain injury (TBI) are at a higher risk of dying from brain cancer compared to the general population. The research, which analyzed data from over 20,000 TBI patients, revealed that those with severe TBI were nearly 14 times more likely to die from brain cancer.

SourceMass General Brigham·JournalNeuroepidemiology·TypeData/statistical analysis·DateJun 10, 2026